Thomas J. Klima - 01 Feb 2022 Form 4 Insider Report for bluebird bio, Inc. (BLUE)

Role
Chief Commercial Officer
Signature
/s/ Helen C. Fu, Attorney-in-Fact
Issuer symbol
BLUE
Transactions as of
01 Feb 2022
Net transactions value
$0
Form type
4
Filing time
03 Feb 2022, 17:07:45 UTC
Previous filing
16 Nov 2021
Next filing
07 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BLUE Common Stock Award $0 +25,000 +50% $0.000000 75,192 01 Feb 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BLUE Stock Option (right to buy) Award $0 +50,000 $0.000000 50,000 01 Feb 2022 Common Stock 50,000 $7.80 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock unit awards vest over a four-year period at the rate of 25% on 01/04/2023, 25% on 01/04/2024, 25% on 01/04/2025, and 25% on 01/04/2026.
F2 This stock option vests over a four-year period at the rate of 25% on 01/04/2023 and then in 36 equal monthly installments thereafter.